@FiercePharma: Budget cuts in Europe squeeze Roche's regional sales by 4%, but U.S. growth of 6% more than offsets it--Reuters. News | Follow @FiercePharma
> Abbott Laboratories ($ABT) has sued Boehringer Ingelheim's Roxane Laboratories unit for patent infringement, saying the company planned to launch a generic version of the HIV drug Norvir before patents expire. Story
> Merck ($MRK) won a new indication for its diabetes drug Januvia in the U.K., for use in patients with moderate-to-severe renal impairment. Article
> Bayer has asked European regulators to approve new uses for its blood-thinner Xarelto: to prevent recurrent deep vein thrombosis and to treat pulmonary embolism. Item
> The combined vaccine against measles, mumps, rubella and chickenpox, or MMRV, does not increase seizure risk in older children, despite the small increase in seizure risk for toddlers. More
> Merck has tapped Codexis to help it develop a more efficient manufacturing process for its hepatitis C drug Victrelis. News
> McKesson ($MCK) won a new contract to supply prescription drugs to the U.S. Department of Veterans Affairs. Report
Biotech News
@FierceBiotech: Experts puzzled over low turnout in cancer trials. Story | Follow @FierceBiotech
@JohnCFierce: The ultimate virtual biotech? Halo scouts for funds to finance mid-stage DMD trial. Not a genetic fix, either. Piece | Follow @JohnCFierce
@RyanMFierce: Google VC doubles down on Big Data after biotech bets. Article | Follow @RyanMFierce
> Gilead's blockbuster hep C gamble takes center stage at EASL. More
> Shire picks up Pervasis in potential $200M deal. Story
> Halo takes the virtual approach to developing a DMD treatment. Article
Medical Devices News
@FierceMedDev: Quest Diagnostics Names Steve Rusckowski as President and CEO. Release | Follow @FierceMedDev
> Quest snags Philips Healthcare head as new CEO. News
> FDA panel wants U-Systems' breast ultrasound approved. Article
> Irish researchers look to up angioplasty success rates. Item
> Sony slashes jobs, boosts med equipment focus. Story
Manufacturing News
> Surya Pharmaceuticals closes 2 Indian API plants. Story
> 3 big animal drugmakers volunteer to change labels. News
> Some supply issues expected from Teva plant in Croatia. More
> Hospira taps drug industry veteran to oversee operations. Article
CRO News
> FDA issues warning to BioMed IRB over its practices. More
> eResearch Technology goes private as lawyers investigate acquisition. Article
> Experts puzzled over low turnout in cancer trials. Story
Vaccines News
> Intellect Neurosciences chases Holy Grail of Alzheimer's: a preventive vaccine. Commentary
> GAVI signs deal for diarrhea vax for world's poorest. Article
> Asthma vaccine hopes rise in preclinical trials. Story
> Vaccine approach could trick immune system. Item
> 'Universal' cancer vaccine not miraculous but could bring hope. More
And Finally... Will pharma stay in the caboose of proactive healthcare? Report